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Joint longitudinal and time-to-event data (single study)
• Methods to simultaneously model potentially related longitudinal and time-to-event data
• Can produce less biased more efficient results than standalone cases where linked 
longitudinal and time-to-event data exists
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Meta-Analysis (MA)
• Systematic pooling of results from multiple studies
• Allows increased precision, identification of effect sizes too small to be identified in 
single studies, and allows questions additional to those originally posed in the data 
to be answered
• Gold standard – Individual Participant/Patient Data (IPD) meta-analyses, where 
data for each individual recorded in studies identified in the meta-analysis is 
available.
Joint longitudinal and time-to-event data (multi-study)
• Data available from multiple studies
• Clustering of data within studies must be accounted for (e.g. through random effects, 
interaction terms, stratified baseline hazard)
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Time-to-event Sub-model
𝜆𝑘𝑖 𝑡 = ℎ 𝑊2, 𝛼
𝜆𝑘𝑖 𝑡 = 𝜆0 𝑡 exp 𝑋2𝛽2 +𝑊2
Study 1 Event time Data
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Approaches to modelling multi-study IPD joint data
• Two main approaches – one stage or two stage
• Two stage approaches
• Separate joint models fitted to data from each study
• Results from each study pooled using standard meta-analytic techniques
• One stage approaches
• Joint model fitted to meta-dataset (containing data from all studies)
• Clustering of data must be accounted for
Real Data – subset of the INDANA dataset
• IPD from multiple studies investigating the effect of no treatment versus any treatment 
for hypertensive patients
• Longitudinal data measured at baseline, 6 months, then annually thereafter to maximum 
of 7 years.  Measurement patterns varied between studies
• Examining longitudinal outcome systolic blood pressure and time-to-event outcome time 
to death
• Evidence of a changepoint in the data at 6 month, so exp −3 ∗ 𝑡𝑖𝑚𝑒 term included in 
the model
Two stage methods
Two stage methods - overview
Stage 1: Joint model fitted to data from each study
Stage 2: Study specific parameters pooled using standard meta-analytic techniques
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• Inverse variance method used (DerSimonian method used for random meta-analyses)
• Both fixed and random effects meta-analyses fitted and compared
• Separate meta-analyses for each parameter of interest
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Two stage methods - recommendations
Preliminary work
• For each study:
• Plot longitudinal trajectories separately for 
those experiencing an event and those 
censored.
• Produce Kaplan-Meier plots for e.g. each 
treatment group
• Use plots to assess whether an association 
between longitudinal and time-to-event outcomes 
is feasible
• Use plots and clinical background of the data to 
select:
• Longitudinal sub-model
• Time-to-event sub-model
• Association structure
Two stage methods - recommendations
First Stage 
• Group studies such that chosen model 
structure within each group is 
identical.
• Within each group, fit identical joint 
models to data from each study.  
Model structures can differ between 
groups.
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Two stage methods - recommendations
Second Stage
• For each study extract model 
parameters, precision estimates and 
sample size
• Pool estimates within groups using 
standard MA techniques. 
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One stage methods
One stage methods - overview
• Same model basic model specification as first stage of two stage work, but now 
additional terms included to account for between study heterogeneity
Group Method to account for between study heterogeneity
0 Between study heterogeneity ignored
1 Fixed interaction term between treatment and study in each sub-model
2 Fixed study indicator in longitudinal sub-model, study level random treatment effect
3 Study level random intercept and random treatment effect
4
Fixed interaction term between treatment and study in longitudinal sub-model, 
baseline hazard stratified by study
5
Fixed study indicator in longitudinal sub-model, study level random treatment effect, 
baseline hazard stratified by study
One stage methods – real data
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Conclusions
• Care must be taken during two stage meta-analyses of joint data to pool only 
parameters with comparable interpretations
• A variety of methods exist to model multi-study joint data in a one stage analyses, 
however some may not be appropriate unless the number of studies in the meta-
analysis is over a given threshold
• Functions for analysis of multi-study joint data available in R package joineRmeta
Thank you for listening.
Any questions?
